Monday, April 15, 2013 10:32:12 AM
From:
Sent: Monday, April 15, 2013 7:31 AM
To: josh.ingle@concordisgroup.com
Subject: RE: Question about today's PR
This is the 4th email that I have sent to you and once again no response. Does anyone answer any investor questions?
From:
Sent: Wednesday, April 10, 2013 12:21 PM
To: josh.ingle@concordisgroup.com
Subject: Question about today's PR
Good afternoon Josh,
Can you answer this simple question. Read this 2011 Concordis PR.
http://www.prnewswire.com/news-releases-test/concordis-group-inc-releases-the-terms-of-purchase-of-advance-underwriting-managers-llc-134667698.html
I notice that the projections for revenue mentioned were approximately 10 million in 2012.
Now let’s go to your 2012 Annual Report.
http://www.otcmarkets.com/financialReportViewer?symbol=CNGI&id=100865
The 2012 revenues are less than $75,000. What happened? This is no where even close to ten million.
BTW, whoever produced that report should have their eyes checked. Very unprofessional as you can’t even get the years right on this annual report. Did you notice the DECEMBER 31, 2012 and 2010 and FOR THE YEARS ENDED DECEMBER 31, 2011 and 2010 on the report ending Dec 31, 2012?
Investors deserve answers.
Join Quikfix's Quick Picks board!
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM